Benefit-risk assessment of ropivacaine in the management of postoperative pain

W Zink, BM Graf - Drug safety, 2004 - Springer
Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996.
In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous …
被引用次数：103 相关文章

Benefit-risk assessment of ropivacaine in the management of postoperative pain

W Zink, BM Graf - Drug safety, 2004 - pubmed.ncbi.nlm.nih.gov
Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996.
In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous …

Benefit-risk assessment of ropivacaine in the management of postoperative pain.

W Zink, BM Graf - Drug Safety, 2004 - europepmc.org
Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996.
In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous …

[引用][C] Benefit-risk assessment of ropivacaine in the management of postoperative pain

W ZINK, BM GRAF - Drug safety, 2004 - pascal-francis.inist.fr
Benefit-risk assessment of ropivacaine in the management of postoperative pain CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Benefit-risk assessment of ropivacaine in the management of postoperative pain

W Zink, BM Graf - Drug Safety, 2004 - go.gale.com
Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996.
In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous …

[引用][C] Benefit-Risk Assessment of Ropivacaine in the Management of Postoperative Pain

W Zink, BM Graf - Drug Safety, 2004 - cir.nii.ac.jp

[引用][C] Benefit-risk assessment of ropivacaine in the management of postoperative pain

Z WOLFGANG - Drug Safety, 2004 - cir.nii.ac.jp

[引用][C] Benefit-risk assessment of ropivacaine in the management of postoperative pain

W ZINK, BM GRAF - Drug safety, 2004 - Adis International